Track Medtech Start-ups

Learn More
innovation hub

Radient Pharmaceuticals (AMEX: RPC) (fka AMDL Diagnostics) is Profiled in this Database

Updated At 04 May, 2011

Start Free 7 Day Trial Now
Partial description of this company
1-Non-invasive in vitro diagnostic (IVD) blood test for the detection and/or monitoring of 14 different types of cancer, 2-Combination Immunogene Therapy (CIT) technology that could lead to a vaccine or possibly treat those already diagnosed with cancer

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Radient Pharmaceuticals (AMEX: RPC) (fka AMDL Diagnostics) plus 4787 other startups.

Start Free 7 Day Trial Now

Learn More About Radient Pharmaceuticals (AMEX: RPC) (fka AMDL Diagnostics)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients